Article

Understanding HIV Transmission Rates

Unprotected sexual exposure to HIV does not necessarily lead to infection.

Unprotected sexual exposure to HIV does not necessarily lead to infection. In fact, some studies have gone as far as to say that successful HIV-1 transmission occurs only 1 of 1000 times.

HIV does not have it easy when trying to establish a new infection. Between genital mucosa, tightly packed epithelial cells, and initial immune responses, there are a number of innate barriers to overcome. But even still, thousands of new infections occur in the United States every year.

As Beatrice Hahn, MD, asked, “What is unique about these transmitted viruses that make it this far?” That’s what she, along with colleagues at the University of Pennsylvania set out to understand.

The researchers examined blood and genital secretions from 4 donors with HIV-1 fully suppressed by antiretroviral therapy (ART) and their matched recipients. They were able to generate 300 virus isolates from individual HIV-1 particles and identify characteristics of the virus strains. This allowed the team to see how the virus got around the genital mucosa, which is meant to block intruders.

It turns out that there’s a sub-population of HIV-1 strains that are naturally predisposed to better establish new infections.

Viruses isolated from the recipients were 3 times more infectious and able to replicated 1.4 higher than those gathered from the donors. In addition, these viruses were much more resistant to two type 1 interferons, IFN-beta and IFN-alpha2—requiring 8-fold and 39-fold higher concentrations, respectively, in order to reduce replication by 50%.

“Knowing the viral properties that confer the ability to transmit despite all of the human body’s barriers to infection, might aid the development of vaccines against HIV-1,” said Hahn, a professor of Medicine and Microbiology in the Perelman School of Medicine at Penn.

Furthermore, the viruses from the recipients were released from infected CD4 immune cells. This indicates that cell-free particle production is key in HIV-1 transmission, the researchers explained.

“This means that rapidly multiplying strains of HIV-1 that are interferon resistant have an increased transmission fitness,” said co-first author Shilpa Iyer, a doctoral student in the Han lab.

A final piece of this research suggests that a virus is less likely to replicate properly with larger clones of proviral sequences.

“But we still don’t know which viral gene products render HIV-1 resistant to interferon and how they function. The next steps will be to dissect these mechanisms to define possible new targets for AIDS prevention and therapy,” Hahn concluded.

The study, “Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNA,” was published in the Proceedings of the National Academy of Sciences. The news release and side photo was provided by the University of Pennsylvania.

Related Videos
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
October is American Pharmacists Month.
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications
Pharmacy Benefit Manager Transparency | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Benefit Manager Regulation | Image Credit: Tyler Olson - stock.adobe.com
Naloxone concept represented by wooden letter tiles.
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication